Cetuximab-Taxanes-Platinum-Fluorouracil/Capecitabine (C-TPF/C-TPX) – a Feasible Option for Recurrent HNSCC with Negative Prognostic Factors. Literature Review with a Case Presentation

Cetuximab-Taxanes-Platinum-Fluorouracil/Capecitabine (C-TPF/C-TPX) – a Feasible Option for Recurrent HNSCC with Negative Prognostic Factors. Literature Review with a Case Presentation

Concurrent chemo-radiotherapy with Cisplatin is the standard treatment for locally advanced non-metastatic squamous cell carcinoma of the head and neck (HNSCC), but induction chemotherapy (IC) followed by chemo-irradiation, even controversial is a widely accepted option, especially in high-risk case...

Full description

Bibliographic Details
Main Authors: Camil Ciprian MIRESTEAN, Roxana Irina IANCU, Mihai Cosmin STAN, Dragos Petru Teodor IANCU, Florinel BADULESCU
Format: Article
Language:English
Published: Media Med Publicis 2023-03-01
Series:Modern Medicine
Subjects:
chemo-radiotherapy
npc
tpf
chemotherapy
cetuximab
carboplatin
capecitabine
Online Access:https://medicinamoderna.ro/wp-content/uploads/2023/03/Cetuximab-Taxanes-Platinum-Fluorouracil-Capecitabine-C-TPFC-TPX-%E2%80%93-a-Feasible-Option-for-Recurrent-HNSCC-with-Negative-Prognostic-Factors.-Literature-R.pdf

Internet

https://medicinamoderna.ro/wp-content/uploads/2023/03/Cetuximab-Taxanes-Platinum-Fluorouracil-Capecitabine-C-TPFC-TPX-%E2%80%93-a-Feasible-Option-for-Recurrent-HNSCC-with-Negative-Prognostic-Factors.-Literature-R.pdf

Similar Items